Array BioPharma Inc.

Array BioPharma Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. This stock has a reasonable momentum. Array BioPharma Inc. has good value characteristics. Array BioPharma Inc. is not very popular among insiders. Array BioPharma Inc. is a mediocre stock to choose.

Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small...

News

ARRAY Technologies Introduces Reusable Packaging Option

Globe Newswire The Company launches reusable plastic packaging to enhance sustainability and reduce costsALBUQUERQUE, N.M., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) ( ARRAY or the...\n more…

ARRAY Technologies Developing Industry-Leading 77-Degree Stow for Enhanced Hail Protection

Globe Newswire The Company continues to invest in new designs and technology to protect solar projects against severe weatherALBUQUERQUE, N.M., Sept. 09, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY...\n more…

The Market Doesn't Like What It Sees From Array Technologies, Inc.'s (NASDAQ:ARRY) Revenues Yet As Shares Tumble 41%

Simply Wall St Unfortunately for some shareholders, the Array Technologies, Inc. ( NASDAQ:ARRY ) share price has dived 41% in the last...\n more…

Array Technologies call volume above normal and directionally bullish

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Analysts Just Shaved Their Array Technologies, Inc. (NASDAQ:ARRY) Forecasts Dramatically

Simply Wall St The latest analyst coverage could presage a bad day for Array Technologies, Inc. ( NASDAQ:ARRY ), with the analysts...\n more…